Rapid response to omalizumab in 3 cases of delayed pressure urticaria.
Department of Allergy and Clinical Immunology, University Hospital of A Coruña, A Coruña, Spain.
Olinda Pérez
OP
Quintero
Department of Allergy and Clinical Immunology, University Hospital of A Coruña, A Coruña, Spain.
Antonio Parra
AP
Arrondo
Department of Allergy and Clinical Immunology, University Hospital of A Coruña, A Coruña, Spain. Electronic address: beatriz.veleiro.perez@sergas.es.
Beatriz
B
Veleiro
D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D004487:Edema; D005260:Female; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology / Q000628:therapy*; D007167:Immunotherapy / Q000379:methods*; D008297:Male; D008875:Middle Aged; D000069444:Omalizumab / Q000627:therapeutic use*; D003668:Pressure Ulcer; D011788:Quality of Life; D016896:Treatment Outcome; D014581:Urticaria / Q000276:immunology / Q000628:therapy*
D018926:Anti-Allergic Agents; D000069444:Omalizumab